Xu Shichang, a lecture professor at the Chinese University of Hong Kong, said that foreign pharmaceutical factories are developing the third -generation crown vaccine, which is expected to be introduced in Hong Kong within two or three months.
Xu Shuchang said on Saturday (August 5) during the interview on the Hong Kong commercial radio program.
He said that foreign pharmaceutical factories are developing the third -generation coronary vaccine, which is a unit -price vaccine for XBB virus.At present, research shows that the effect of antibodies is good. Hong Kong is expected to introduce this vaccine within two or three months.
He also said that if the Hong Kong community is still popular in the Hong Kong community, the use of the vaccine will have better results, which can reduce the risk of severe and death after infection.Once you can be vaccinated once.
However, Xu Shichang pointed out that, including the high -risk group of the elderly and the patients with long -term diseases, the reinforcement agent should be vaccinated in time, and the third -generation vaccine should not be used to get the injection.
Xu Shichang said that Hong Kong's recent influenza diagnosis ratio reached 8.6%, gradually approaching 9.2%of the baseline level, and small influenza eruptions may occur.He said that during the epidemic, many people had not been exposed to influenza viruses, and there were no antibodies in their bodies, and they encouraged citizens to vaccinate influenza vaccines as soon as possible.
For a 25 -month -old baby boy who was infected with the dangerous influenza in infected earlier, Xu Shichang said that there are four cases of death related to children in Hong Kong this year.Pay attention to returning to school after the summer vacation, pay attention to personal hygiene.
